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Abstract
Background/Aim. Basal cell carcinoma (BCC) is one of
the most common malignant skin tumors on the head in
90% of cases and is characterized by a high local infiltrating
potential and destructive growth.  The aim of this study was
to show the characteristics of a correlation between patho-
histological types of basal cell carcinoma and the size of this
lesion, aggressiveness and infiltration of basal cell carci-
noma, and its effect on the course of the therapy. Methods.
We analyzed 27 patients operated on for BCC that affected
the scalp and the bone. We described and considered the
clinical characteristics (size, depth of invasion), duration and
speed of intracranial propagation and then made compari-
son with the type of BCC. We described the extent of surgi-
cal treatment and the width of excision to determine the
best course of the treatment. The patients went through ex-
aminations during the next three years. Results. According
to the histopathological type the most common tumors
were: infiltrative (60.2%), noduloinfiltrative (37.2%), and
morpheaform (2.6%). Tumors were clinically manifested as
ulcerative lesions, ulcus rodens and ulcus terebrans. Tumor di-
ameters ranged from 2 to 25 cm. The depth of intracranial
propagation depended on the histological type and tumor
size. Most relapses (35%) occurred with morpheaform type
of BCC. In 17 of the cases, BCC affected the bone without
intracranial propagation. In 10 of the cases, basalioma infil-
trated intracranial space – in 8 of the cases it infiltrated the
dura and in 6 of the cases the brain parenchyma, of which
in two of them, the superior sagittal sinus was affected and
had to be surgically tied off. Conclusion. The aggressive-
ness and infiltration of basal cell carcinoma into the brain
parenchyma is directly linked to the histological type and
the size of the tumor. The larger the basalioma or if histo-
pathological findings confirm morpheaform type of basali-
oma the larger surrounding healthy tissue, sometimes more
than 3 cm in diameter, needs to be removed. In cases of
these tumors postoperative radiotherapy is recommended.
Key words:
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Apstrakt
Uvod/Cilj. U predelu poglavine javlja se veliki broj tumo-
roznih promena. Tumorozne promene na glavi javljaju se
kod 90% sluÿajeva i odlikuju se lokalnim infiltrativnim a
ponekad i destruktivnim rastom. Cilj ovoga rada bio je ana-
liza bazocelularnog karcinoma sa intrakranijalnom propaga-
cijom, karakteristika i korelacija izmeĀu patohistološkog ti-
pa, veliÿine tumora, infiltracione agresivnosti i naÿina leÿe-
nja. Metode. Analizirali smo 27 bolesnika operisanih zbog
bazocelularnog karcinoma sa zahvaýenim koštanim tkivom
poglavine. Opisali smo i prouÿavali kliniÿke karakteristike
(veliÿinu, dubinu invazije), vreme trajanja i brzinu intrakra-
nijalne propagacije, a zatim ih uporeĀivali sa tipom bazoce-
lularnog karcinoma. Razmatrali smo radikalnost operacije i
širinu ekscizije i procenjivali najbolju hiruršku intervenciju.
Bolesnike smo pratili tri godine nakon operacije. Rezultati.
Prema patohistološkom tipu karcinoma, najzastupljeniji bili
su: infiltrativni (60,2%), noduloinfiltrativni (37,2%) i morfo-
eiformni (2,6%) tip. Kliniÿki su se manifestovali kao ulcero-
zne lezije: ulcus rodens i ulcus terebrans. Veliÿina tumora kretala
se od 2 do 25 cm u preÿniku. Dubina intrakranijalne propa-
gacije zavisila je od histološkog tipa i veliÿine tumora. Naj-
veýi broj recidiva (35%) bio je prisutan kod morfoeiform-
nog tipa bazocelularnog karcinoma. Kod 17 bolesnika bazo-
celularni karcinom je bio zahvatio kost bez propagacije in-
trakranijalno, a vreme trajanja promene bilo je od jedne do
dve godine.  Kod 10 bolesnika bazeliom je bio prodro intra-
kranijalno i to u osam infiltrisao duru, a kod šest moždani
parenhim, od toga kod dva bolesnika bio je zahvaÿen sinus
sagittalis koji je morao biti podvezan. Zakljuÿak. Agresiv-
nost i infiltracija bazocelularnog karcinoma u moždani pa-
rehhim direktno su uslovljeni histološkim tipom i veliÿinom
tumora. Što je bazeliom veýi ili ako je prema patohistološ-
kom nalazu morfoeiformni tip mora se izvršiti veýe otkla-
njanje okolnog zdravog tkiva, nekada više od 3 cm u preÿ-
niku, uz postoperativnu radiološku terapiju.
Kljuÿne reÿi:
glava i vrat, neoplazme; karcinom, bazocelularni;
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Introduction
Carcinoma basocellulare originates from pluripotent
cells of the basal layer of the epidermis, the outer layer of
hair follicles, sebaceous glands or other skin adnex 
1–2. It is
characterized by local infiltrative and sometimes destructive
growth. It very rarely gives metastases. In the scalp region a
large number of tumorous lesions appear. Some types of
cancer can be very aggressive and by location they can be
intracranial with extracranial propagation or extracranial
with intracranial propagation. One type of tumor that is by
localization extracranial and has intracranial propagation are
basal cell carcinomas.
There are several histological types of basocelular car-
cinoma 
2 which may be manifested in over a dozen clinical
forms. The most aggressive is infiltrating form which is usu-
ally clinically manifested as: carcinoma basocellularae ul-
cerosum ( exulcerans) s.  ulcus rodens – it appears as a
sharply defined ulcerative lesion of various sizes and depths,
with  irregular edges 
3–4. The bottom appears as a crater cov-
ered with bloody discharge, hypergranulation and crust and
easily bleeds. It grows very fast and infiltratively, devastat-
ing the surrounding tissue down to the cartilage and bone;
carcinoma basocellulare terebrans, s. ulcus terebrans – it
develops from ulcus rodens with a deeper and more exten-
sive tissue destruction and decay. The tumor penetrates and
infiltrates and destroys the subcutis, fascia, muscles and car-
tilage, bones 
4. Extensive mutilations and deformities appear
with bleeding and secondary infections. They usually occur
on the scalp and the middle of the face and are very difficult
to treat 
4;  carcinoma basocellulare morpheaform ( sclero-
dermiform) – a less frequent clinical form, more common on
the head as a small, raised yellow or white plate with a net-
work of telangiectasia on the surface. This type of basocelu-
lar cacinoma is radioresistant.
Surgical treatment largely depends on the histological
type, size, location and the depth of the intracranial propaga-
tion and its clinical manifestations.
Methods
We analyzed 27 patients operated on for basal cell car-
cinoma affecting the scalp and bone, of both sexes and dif-
ferent ages. We studied the clinical characteristics of basal
cell carcinoma affecting the bone scalp. We described: the
size, the depth of invasion, duration and speed of intracranial
propagation and then made comparison with the histopatho-
logic types i.e. the type of basal cell carcinoma.
We used multidisciplinary methodology, including the
specialist in plastic surgery. Surgical treatment consisted of
excision of basal cell changes, and closure of secondary de-
fects with skin grafts and flap reconstruction depending on
the location and size. We entered the following data in the
protocol: age, sex, lesion diameter, duration and anatomic
site. Preparations were placed in 1% formaldehyde and sent
to histopathological (HP) verification. After receiving the HP
findings we entered in the protocol the data on the presence
of tumor tissue at the edges of the resection and the histo-
pathologic type of basal cell carcinoma. On the basis of their
clinical characteristics we compared the histopathologic type
and the type of basal cell carcinoma and then described the
radicality of surgery and the width of excision to determine
the best surgical treatment. The patients were followed three
years after the surgery. The diagnostic methods we used
were computed tomography (CT), magnetic resonance (MR)
and 64-multislice CT (MSCT) as a very accurate diagnostic
procedure.
Results
Out of 27 analyzed patients with basal cell carcinoma
15 (56%) were male and 12 (44%) female. The age structure
of the patients ranged from 82 years to 43 years (with the av-
erage age of ʉ = 62 years). Tumor size ranged from 2 cm to
25 cm in diameter (average value of ʉ = 3.8 cm). In relation
to the anatomic site basal cell carcinomas were usually pres-
ent in the frontal region (22%), parietal (31%), in the tempo-
ral (33%), and in the occipital region (14%).
By histopathologic type the most common were: infil-
trative (60.2%), noduloinfiltrative (37.2%) and morpheaform
(2.6%). They were clinically manifested as: ulcerative, ulcus
rodens and ulcus terebrans (Figure 1). Non-infiltrative basal
cell carcinoma (nodular, noduloadenoid and superficial) did
not affect the bony part of the scalp and did not make intra-
cranial penetration. The duration of the changes, i.e. the time
between noticing and the first consultation with the doctor
ranged from 6 months up to 3 years. Tumor sizes ranged
from 2 to 25 cm in diameter. The depth of the intracranial
propagation depended on the histological type and tumor
size. Most relapses (42%) were present in the morpheaform
type of basal cell carcinoma. In 17 cases the basaliom af-
fected only the bone without intracranial propagation and the
duration of changes ranged from one to two years. In 10
cases the basalioma penetrated intracranially (duration of
changes over three years), of which in 8 cases the duru and
in 6 cases it infiltrated the brain parenchyma, of which in two
a)  b)  c)  d)
Fig. 1 – a) Clinical manifestation of infiltrative basal cell carcinoma; b) Intracranial propagation of the tumor and “Banana
Peel” lifted flaps and reconstructed secondary defect by Orticochea; c) Front view; d) Top view.Volumen 71, Broj 11 VOJNOSANITETSKI PREGLED Strana 1047
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cases the sagittal sinus was affected and had to be tied off
(Figure 2). In all the cases with the brain parenchyma in-
vaded we removed basalioma down to the macroscopically
and microscopically healthy brain parenchyma and in all the
cases we implemented radiotherapy.
Discussion
Despite the fact that basal cell carcinomas are affected
by radiation therapy (except for the morpheaform type),
cryotherapy, curettage, local cytostatic therapy, retinoids or
electrodisection, surgical treatment is the method of choice
in the treatment of this type of tumor 
5–10. Surgically, the tu-
mor can be entirely removed with safe histopathological
checkup and confirmation 
11, 12.
The rate of healing in surgical excisions ranges from
85% to 95% 
5. Epstein 
9 finds that the visual assessment of
basal cell carcinoma edges is within 1 mm from the right
edge in about 94% of cases, which led him to conclude that
the edges of 2 mm give 94% healing. Burg et al. 
11 compared
the clinical size of the tumor estimated by the naked eye with
the right size determined by Mohsov’s micrographic exami-
nation and received the distinction of 5.5 r 3 mm in primary
basocelular carcinomas and 8.9 r 4.8 mm in recurrent basal
cell carcinomas.
Based on the received results and clinical experience
we believe that the width of excision and the presence of tu-
morous cells on the resection lines are in direct correlation
with the histological type and size of basal cell carcinoma.
So, the adequacy of surgical excision is directly dependent
on the type and size of basal cell carcinoma.
We found that in all our cases with the affected scalp
bone tissue and intracranial propagation, it was an infiltrative
basal cell carcinoma and all its histological combinations with
infiltrative component (no macroscopically visible edge com-
pared to the healthy tissue), and that it required wider excision
and depended on the clinical manifestation of the tumor and its
size
4, 13–17. If it is the infiltrative type (clinically most often
with ulceration and covered with crust) and if it is larger than 1
cm (clinically most often manifested as ulcus rodens or ulcus
terebrans excision should be made into the healthy tissue for
about 1.5 cm to 3 cm, sometimes even more.
Noduloinfiltrative histological type is most often clini-
cally manifested as nodus accompanied by tissue decay, ul-
ceration. Because of the clinically present nodus it sometimes
misleads in terms of the evaluation of the excision width
(therefore a high percentage of the presence of tumor at the re-
section edge) 
17–24. But with this kind, there is no clear visual
limits of tumor from healthy skin which requires, depending
on the size, at least 5 mm excision into the healthy tissue.
In the morpheaform type of basal cell carcinoma (rate
of the presence at resection lines 35%) excisions need to be
made into the healthy tissue up to 3 cm from the tumor edge
which is not macroscopicly clearly defined. In the diagnosis
of the width of excision in morpheaform basal cell carcino-
mas we used 64-slice MSCT.
Conclusion
The aggressiveness and infiltration of basal cell carci-
noma into the brain parenchyma is directly linked to the his-
tological type and size of the tumor. The larger the basal cell
carcinoma the wider excisions need to be made into the
healthy tissue with obligatory removal of the affected bone
down to the macroscopicly and microscopicly healthy brain
parenchyma sometimes up to 3 cm in diameter with obliga-
tory postoperative radiological therapy.
REFERENCES
1. Yenidunya MO. Surgical treatment of auricular malignancies
when the anterior or posterior skin is intact. J Craniofac Surg
2013; 24(2): 350î3.
2. Braun-Falco O, Plewig G, Wolff HH, Winkeimann RK. Malignant epithe-
lial tumors. In: Braun FO, Plewig G, Wolff HH, Winkeimann RK, edi-
tors. Dermatology. Berlin: Springer-Verlag; 1991. p. 1018î35.
a)  b)  c)  d)
e)   f)
Fig. 2 – a) Clinical manifestation of infiltrated basal cell carcinoma (ulcus terebrans); b) Marked lines represent the site of
delamination of free microvascular latissimus dorsi flap; c) Clear invasion of carcinoma into the tissue (which is much larger
than the skin invasion) with the affected sinus sagittalis; d) Prepared a. and v. occipitalis; e) microvascular anastomosis a.v.
occipitalis and a.v. thoracodorsalis; f) vital microvascular flap latissimus dorsi.Strana 1048 VOJNOSANITETSKI PREGLED Volumen 71, Broj 11
Rasuliý GL, Jovanoviý MD. Vojnosanit Pregl 2014; 71(11): 1045–1048.
3. Wade TR, Ackerman AB. The many faces of basal-cell carci-
noma. J Dermatol Surg Oncol 1978; 4(1): 23î8.
4. Marshall V. Premalignant and malignant skin tumours in im-
munosuppressed patients. Transplantation 1974; 17(3): 272î5.
5. Araújo JL, Aguiar GB, Prado AU, Mayrink D, Saade N, Veiga JC.
Malignant chondroid syringoma with central nervous system
involvement. J Craniofac Surg 2012; 23(2): 514î5.
6. Ronÿeviý R, Aleksiý V, Stojiÿiý M, Jovanoviý M, Ronÿeviý D. Invasive,
aggresive basal cell carcinoma: Carcinoma basocellulare tere-
brans. Eur J Plast Surg 2006; 23: 379î84.
7. Vuloviý D, Stepiý N, Pavloviý A, Miliýeviý S, Pisceviý B . Recon-
struction of the columella and the tip of the nose with an is-
land-shaped forehead flap. Vojnosanit Pregl 2011; 68(3):
277î80. (Serbian)
8. Beatty ME, Habal MB. De novo cutaneous neoplasm: Biologic
behavior in an immunosuppressed patient. Plast Reconstr Surg
1980; 66(4): 623î7.
9. Epstein E. How accurate is the visual assessment of basal car-
cinoma margins. Br J Dermatol 1973; 89(1): 37î43.
10. Longobardi G, Diana G, Poddi V, Pagano I. Follicular cyst of the
jaw developing into a keratocyst in a patient with unrecognized
Gorlin-Goltz syndrome. J Craniofac Surg 2010; 21(3): 833î6.
11. Burg G, Hirsch RD, Konz B, Braun-Falco O. Histographic surgery:
Accuracy of visual assessment of the margins of basal-cell
epithelioma. J Dermatol Surg 1975; 1(3): 21î4.
12. Deo SV, Hazarika S, Shukla NK, Kumar S, Kar M, Samaiya A.
Surgical management of skin cancers: Experience from a re-
gional cancer centre in North India. Indian J. Cancer 2005;
42(3): 145î50.
13. Pennington BE, Leffell DJ. Mohs micrographic surgery: Estab-
lished uses and emerging trends. Oncology (Willston Park)
2005; 19(9): 1165î71; discussion 1171î2, 1175.
14. Bojanoviý M, Zivkoviý-Marinkov E, Veselinoviý D, Bojanoviý A,
Vuckoviý I. Malignant tumors of auricula and periauricular area.
Vojnosanit Pregl 2009; 66(8): 611î6. (Serbian)
15. Hutcheson AC, Fisher AH, Lang PG. Basal cell carcinomas with
unusual histologic patterns. J Am Acad Dermatol 2005; 53(5):
833î7.
16. McCutcheon B, White K, Kotwall C, Germolic D, Rebolloso Y, Ha-
mann MS, et al. A preliminary study of imiquimod treatment in
variants of basal cell carcinoma. Am Surg 2005; 71(8): 662î5.
17. Asilian A, Tamizifar B. Aggressive and neglected basal cell car-
cinoma. Dermatol Surg 2005; 31(11 Pt 1): 1468î71.
18. Steve M, Paranque AR, Barthélémy I, Bui P. Management of a ba-
socellular carcinoma of the cheek. Rev Stomatol Chir Maxillo-
fac 2008; 109(1): 56î60.
19. Anwar U, Ghazal AS, Ahmad M, Sharpe DT. Horrifying basal
cell carcinoma forearm lesion leading to shoulder disarticula-
tion. Plast Reconstr Surg 2006; 117(1): 6eî9e.
20. Eisner JM, Russell M. Cartilage hair hypoplasia and multiple ba-
sal cell carcinomas 2006; 54(2 Suppl): S8î10.
21. Ríos-Buceta L. Management of basal cell carcinomas with positive
margins. Actas Dermosifiliogr 2007; 98(10): 679î87. (Spanish)
22. Su SY, Giorlando F, Ek EW, Dieu T. Incomplete Excision of
Basal Cell Carcinoma: A Prospective Trial. Plast Reconstr Surg
2007; 120(5): 1240î8.
23. Wettstein R, Erba P, Farhadi J, Kalbermatten DF, Arnold A, Haug
M, et al. Incomplete excision of basal cell carcinoma in the
subunits of the nose. Scand J Plast Reconstr Surg Hand Surg
2008; 42(2): 92î5.
24. Gargiulo M, Papa A, Capasso P, Moio M, Cubicciotti E, Parascandolo
S. Electrochemotherapy for non-melanoma head and neck
cancers: clinical outcomes in 25 patients. Ann Surg 2012;
255(6): 1158î64.
Received on September 3, 2013.
Accepted on September 26, 2013.